0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology

Buy Now

Boron Neutron Capture Therapy - Toward Clinical Trials of Glioma Treatment (Paperback, Softcover reprint of the original 1st ed. 1992) Loot Price: R1,490
Discovery Miles 14 900
Boron Neutron Capture Therapy - Toward Clinical Trials of Glioma Treatment (Paperback, Softcover reprint of the original 1st...

Boron Neutron Capture Therapy - Toward Clinical Trials of Glioma Treatment (Paperback, Softcover reprint of the original 1st ed. 1992)

Detlef Gabel; Adapted by Renate Alberts; Edited by Raymond Moss

 (sign in to rate)
Loot Price R1,490 Discovery Miles 14 900 | Repayment Terms: R140 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

The European Collaboration on Boron Neutron Capture Therapy (BNCT), conceived in 1987 and successful in 1989 in gaining financial support as a Concerted Action through the Medical and Health Research Programme of the Commission ofthe European Communities (CEC) in Brussels, considered it an opportune moment to hold its annual Plenary Meeting on 18-20 Septem ber 1991 as an International Workshop entitled "Towards Clinical Trials of Glioma with BNCT". The background to this consideration was influenced by the world-wide resurgence ofinterest in NCT over the last 2 decades and by the exemplifica tions at the Fourth International Symposium on Neutron Capture Therapy for Cancer held in Sydney in December 1990, where it was strongly indicated that within the next 2 years clinical trials would be started both in Europe and the United States. In particular at the High Flux Reactor of the Joint Research Centre of the CEC at Petten in The Netherlands, an epithermal neutron beam designed and installed in the summer of 1990 recently became operable at full reactor power. An extensive series ofexperiments, including the nuclear and radiobiological characterisation of the beam and a healthy tissue tolerance study on canines has started and has the aim to define the preconditions for clinical trials onpatients with Grade III/IV glioma. However, as with any other new therapy modality, it must be demon strated that BNCT is safe for the patient and has a reasonable chance of being an effective therapy.

General

Imprint: Springer-Verlag New York
Country of origin: United States
Release date: March 2013
First published: 1992
Editors: Detlef Gabel
Adapted by: Renate Alberts
Editors: Raymond Moss
Dimensions: 254 x 178 x 15mm (L x W x T)
Format: Paperback
Pages: 279
Edition: Softcover reprint of the original 1st ed. 1992
ISBN-13: 978-1-4613-6506-8
Categories: Books > Medicine > Other branches of medicine > Nuclear medicine
Books > Medicine > Other branches of medicine > Pharmacology > General
Books > Medicine > Other branches of medicine > Medical imaging > Ultrasonics
Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > General
LSN: 1-4613-6506-6
Barcode: 9781461365068

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners